BIO-GATE AG (BIG1.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:BIG1 - DE000BGAG981 - Common Stock
BIG1.DE Key Statistics, Chart & Performance
The current stock price of BIG1.DE is 0.83 EUR. In the past month the price decreased by -2.35%. In the past year, price increased by 6.41%.
BIG1.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AKZA.AS | AKZO NOBEL N.V. | 16.19 | 10.08B | ||
| AKU1.DE | AKZO NOBEL N.V. | 16.11 | 10.03B | ||
| SY1.DE | SYMRISE AG | 19.07 | 9.67B | ||
| SYENS.BR | SYENSQO SA | 22.14 | 7.48B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.81 | 6.22B | ||
| 1EVK.MI | EVONIK INDUSTRIES AG | 7.95 | 6.18B | ||
| NVJP.DE | UMICORE | 17.45 | 4.86B | ||
| UMI.BR | UMICORE | 17.27 | 4.81B | ||
| AKE.PA | ARKEMA | 10.32 | 4.04B | ||
| WCH.DE | WACKER CHEMIE AG | 163.14 | 3.66B | ||
| RBT.PA | ROBERTET SA | 18.53 | 1.89B | ||
| ACT.DE | ALZCHEM GROUP AG | 25.64 | 1.59B |
Related stock screener links
About BIG1.DE
Company Profile
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 46 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
Company Info
BIO-GATE AG
Neumeyerstrasse 28-34
Nuremberg BAYERN DE
Employees: 46
Phone: 49911477523100
BIO-GATE AG / BIG1.DE FAQ
What does BIG1 do?
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 46 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
What is the current price of BIG1 stock?
The current stock price of BIG1.DE is 0.83 EUR. The price increased by 1.22% in the last trading session.
Does BIO-GATE AG pay dividends?
BIG1.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of BIG1 stock?
BIG1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is BIO-GATE AG (BIG1.DE) stock traded?
BIG1.DE stock is listed on the Frankfurt Stock Exchange exchange.
Can you provide the market cap for BIO-GATE AG?
BIO-GATE AG (BIG1.DE) has a market capitalization of 7.67M EUR. This makes BIG1.DE a Nano Cap stock.
Who owns BIO-GATE AG?
You can find the ownership structure of BIO-GATE AG (BIG1.DE) on the Ownership tab.
BIG1.DE Technical Analysis
BIG1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BIG1.DE. The financial health of BIG1.DE is average, but there are quite some concerns on its profitability.
BIG1.DE Financial Highlights
Over the last trailing twelve months BIG1.DE reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 31.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.97% | ||
| ROE | -151.1% | ||
| Debt/Equity | 0 |
BIG1.DE Forecast & Estimates
8 analysts have analysed BIG1.DE and the average price target is 3.06 EUR. This implies a price increase of 268.67% is expected in the next year compared to the current price of 0.83.
For the next year, analysts expect an EPS growth of 30.3% and a revenue growth 0.33% for BIG1.DE